Funding for this research was provided by:
(75N93019C00062, R01 AI073755)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Received: 7 April 2020
Accepted: 29 September 2020
First Online: 19 October 2020
: M.S.D. is a consultant for Inbios, Vir Biotechnology, NGM Biopharmaceuticals, Carnival Corporation and on the Scientific Advisory Board of Moderna and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, and Emergent BioSolutions. J.E.C. has served as a consultant for Takeda Vaccines, Sanofi-Aventis., Pfizer, and Novavax, is a member of the Scientific Advisory Boards of CompuVax and Meissa Vaccines, and is the founder of IDBiologics. G.R.S. is on the Scientific Advisory Board for GSK Vaccines. G.A. is a founder of Systems Seromyx Inc. The Alter laboratory has received funding from Janssen, Merck, Sanofi, Pfizer, GlaxoSmithKline, Bristol Myers Squibb, and Gilead. All other authors declare no competing interests.